Board-certified obesity medicine physicians prescribing GLP-1s. Often insurance-covered — among the most affordable options when insurance applies.
PCOS-focused platform with phenotype-driven treatment matching. Specialist providers only.
Primary care telehealth that prescribes Wegovy and Zepbound when clinically appropriate. Insurance-friendly.
Hormone testing and replacement platform expanded to women’s HRT in 2024. At-home lab kits + clinician follow-up.
Integrative PCOS platform combining endocrinology, dietitian visits, and mental health support.
Calibrate’s insurance-billing arm for women whose employer plan covers Wegovy or Zepbound.
Noom’s GLP-1 telehealth arm pairing semaglutide/tirzepatide prescribing with behavior-change coaching.
Hims & Hers' weight loss division offering compounded GLP-1s plus FDA-approved options. Among the most affordable starting prices.
Async PCOS prescribing for acne, hirsutism, and irregular cycles. Affordable monthly plans.
WW’s clinical arm (formerly Sequence) prescribing GLP-1s integrated with the WW behavior program.
Boutique anti-aging clinic offering bioidentical HRT, including injectable estradiol and testosterone for women.
WeightWatchers-acquired clinical weight loss program. Connects you with board-certified clinicians who can prescribe FDA-approved GLP-1s.
Doctor-led GLP-1 weight loss program. Offers compounded semaglutide/tirzepatide and FDA-approved Wegovy/Zepbound for eligible patients.
Personalized menopause care with FDA-approved hormonal and non-hormonal options. Async chat with clinicians, medications shipped to your door.
Reproductive health platform with PCOS-friendly fertility prep, ovulation tracking, and Rx coordination.
GLP-1-focused DTC platform offering compounded semaglutide and tirzepatide with monthly delivery.
Hers launched menopause vertical in 2024. Async-first HRT with focus on affordability and speed.
Cash-pay menopause telehealth offering bioidentical HRT (compounded and FDA-approved). Subscription with medications shipped monthly.
Year-long metabolic health program combining GLP-1 medication with intensive 1:1 coaching. Premium price point, strong outcomes data.
Whole-person weight loss with GLP-1 medication plus behavioral coaching. One of the larger GLP-1 telehealth programs.
New 2024 entrant focused on women-led GLP-1 prescribing with PCOS comorbidity awareness.
Menopause-focused brand expanded in 2024 from OTC products to telehealth HRT prescribing.
Mental health platform expanded to perimenopausal mood and sleep treatment. SSRI/SNRI plus therapy.
Direct-to-clinician marketplace where users find providers willing to prescribe compounded semaglutide.